Drug Type Small molecule drug |
Synonyms OXM 2, OXM2 |
Target |
Mechanism CCR6 modulators(CCR6 chemokine modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoimmune Diseases | Preclinical | US | 10 Jul 2024 |